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Abstract
Introduction: Lung cancer metastasizing to the face
has rarely been reported and is an even more unusual
presentation. Case: This is the case of a 49-year-old
man diagnosed with squamous cell carcinoma of the
face, scheduled for resection. Preoperative radio-
graphs revealed a left upper lobe mass, found to be
squamous cell carcinoma. Diagnosis was changed to
Stage IV primary lung cancer. The patient did not
undergo resection. Discussion: No previous cases of
primary lung cancer presenting as a malar mass have
been reported. Facial lesions can be the presenting
feature of primary lung cancer. Discovery of the true
primary lesion can alter therapy and prognosis.
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Introduction
Primary lung cancers commonly involve other structures by
direct extension or metastasis. Metastatic disease may
involve lymph nodes, mediastinal structures, chest wall,
pleura, other areas of lung parenchyma, and extrathoracic
organs. Extrathoracic metastases occur in over one third of
cases and typically reflect pulmonary microvascular inva-
sion [1]. Extrathoracic manifestations occur but are seldom
the presenting finding [2]. The potential for metastasis
occurs more commonly in small cell cancer than in non
small cell cancer [1]. Of non small cell lung cancers, large
cell carcinoma and adenocarcinoma have a greater pro-
pensity for metastasis than do squamous cell cancers [1].
Common sites for metastases include the brain, liver,
bone, and adrenal glands, but virtually any organ may be
affected. Lung cancer metastasizing to the face has rarely
been reported and is even more unusual as the initial
presentation. We present a patient who was initially diag-
nosed with a primary head and neck malignancy, which
was later found to be a metastatic lesion from primary non
small cell lung cancer.
Case Report
A 49-year-old man presented for evaluation of a rapidly
expanding mass on his right cheek. He initially noted a small
nodule adjacent to his zygomatic arch 2 months prior. He
presented subsequent loss of peripheral vision due to the
lesion’s mass effect. He also reported dyspnea on exertion,
cough, night sweats, malaise, anorexia, and a 20-lb uninten-
tional weight loss over the preceding 2 months. The patient
reported a current 54 pack year history of smoking, but denied
excessive alcohol use.
On presentation, the patient was found to have a 4-cm, firm,
and immobile mass of his right malar ridge. Field of vision was
limited by mass effect, but extraocular muscles were intact.
The buccal mucosa and oropharynx were without lesions and
there was no significant adenopathy. Vital signs and laboratory
values were within normal limits. A computed tomography (CT)
scan showed a 3.4  3.0  3.9 cm enhancing soft tissue mass
within the right premalar region with associated bony destruc-
tion and extension into adjacent structures (Figure 1). Needle
biopsy showed poorly differentiated carcinoma and surgical
resection was scheduled.
Preoperative chest radiographs and subsequent CT
(Figure 2) showed a 3-cm mass in the left upper lobe with
lobar collapse, chest wall extension, and mediastinal adenop-
athy. Fiber optic bronchoscopy revealed a near-complete
obstruction of the left mainstem bronchus with complete col-
lapse of the left upper lobe. Cytobrush and endobronchial
biopsies revealed squamous cell carcinoma. Surgical biopsy
confirmed similar pathology in the malar mass.
The patient’s diagnosis was changed to Stage IV primary
non small cell lung cancer. Surgical resection of his malar mass
was cancelled and he was referred to medical and radiation
oncology for palliative therapy. He began external beam radi-
ation, with 5000 cGy to the right malar eminence, 3500 cGy to
the mediastinum, and 5000 cGy to the left lung mass, followed
by carboplatin (Paraplatin; Bristol-Myers Squibb, New York,
NY) and paclitaxel (Taxol; Bristol-Myers Squibb).
Discussion
Metastatic disease is a frequent complication of primary lung
cancer. Lung cancer may metastasize by both lymphatic and
hematogenous spread. Potential for metastasis is more likely
related to the location, and not the size, of the primary tumor [3].
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The frequency of extrathoracic metastasis varies according
to histological findings and degree of cancer differentiation
[3]. Poorly differentiated squamous cell lung cancers have a
greater risk of extrathoracic metastasis than do well-differ-
entiated tumors of the same cell type [3].
The most common sites of extrathoracic metastases
include the adrenal glands, brain, bone, and liver, typically
by hematogenous spread. Adrenal metastases are present
at autopsy in 35% of patients with non small cell lung cancer
[1]. Central nervous system metastasis occurs in 10% of
cases at presentation, and 50% to 60% at autopsy [1]. Liver
metastases are found in 30% to 45% of patients at autopsy
[1]. Bone metastases are found at autopsy in 25% to 40% of
cases and typically results in osteolytic lesions to the
trabeculae [1].
Primary lung cancer metastasizing to facial structures has
rarely been reported. Barnard [4] reports a patient who
present with a squamous cell carcinoma of the buccal
mucosa, later found to be metastasis from a primary lung
cancer. Whyte [5] describes a patient presenting with undif-
ferentiated oat cell carcinoma of the temporal fossa second-
ary to a primary lung cancer. One previous report describes
recurrence of squamous cell carcinoma involving the malar
ridge in a patient with a known history of lung cancer [6]. The
presented patient is the first reported case of primary non
small cell lung cancer presenting as a malar mass.
Although uncommon, facial lesions can be the presenting
feature of a primary lung cancer. Symptoms, such as dys-
pnea and cough, are less commonly associated with other
primary cancers and should raise suspicions for an underly-
ing pulmonary malignancy. Common malignancies can me-
tastasize to uncommon sites and, although infrequent, may
be the presenting feature. Less common malignancies,
especially when associated with symptoms suggestive of
another primary malignancy, should raise the suspicion for
metastatic disease. Discovery of the true primary lesion, as
in this case, can alter the therapy and prognosis in patients
with cancer.
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Figure 1. CT of the head. CT of the face with contrast showed a 3.4  3.0 
3.9 cm enhancing soft tissue mass involving the right premalar tissues with
sinus and orbit extension.
Figure 2. CT of the chest. CT of chest with contrast revealed a 2.9  2.7 cm
mass compressing the left upper lobe bronchus with lobar collapse, chest wall
extension, and mediastinal adenopathy.
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